tiprankstipranks
Trending News
More News >
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
US Market

Defence Therapeutics (DTCFF) Technical Analysis

Compare
14 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Defence Therapeutics’s (DTCFF) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Defence Therapeutics is a Buy.
Defence Therapeutics’s (DTCFF) 20-Day exponential moving average is 0.65, while Defence Therapeutics’s (DTCFF) share price is $0.56, making it a Sell.
Defence Therapeutics’s (DTCFF) 50-Day exponential moving average is 0.71, while Defence Therapeutics’s (DTCFF) share price is $0.56, making it a Sell.

Defence Therapeutics (DTCFF) Pivot Points

Jun 12, 2025, 12:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.51
0.53
0.54
0.56
0.58
0.60
0.62
Fibonacci
0.53
0.54
0.55
0.56
0.58
0.59
0.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Defence Therapeutics (DTCFF) Moving Averages

Jun 12, 2025, 12:20 AM
Period
Simple
Exponential
MA5
0.56Buy
0.57Sell
MA10
0.61Sell
0.60Sell
MA20
0.69Sell
0.65Sell
MA50
0.73Sell
0.71Sell
MA100
0.79Sell
0.71Sell
MA200
0.60Sell
0.62Sell
Defence Therapeutics’s (DTCFF) 10-Day exponential moving average is 0.60, while Defence Therapeutics’s (DTCFF) share price is $0.56, making it a Sell.
Defence Therapeutics’s (DTCFF) 100-Day exponential moving average is 0.71, while Defence Therapeutics’s (DTCFF) share price is $0.56, making it a Sell.
Defence Therapeutics’s (DTCFF) stock price is $0.56 and Defence Therapeutics’s (DTCFF) 50-day simple moving average is 0.73, creating a Sell signal.
Defence Therapeutics’s (DTCFF) stock price is $0.56 and Defence Therapeutics’s (DTCFF) 100-day simple moving average is 0.79, creating a Sell signal.
Defence Therapeutics’s (DTCFF) stock price is $0.56 and Defence Therapeutics’s (DTCFF) 200-day simple moving average is 0.60, creating a Sell signal.

Defence Therapeutics (DTCFF) Technical Indicators

Jun 12, 2025, 12:20 AM
Name
Value
Implied Action
RSI (14)
21.48
Buy
STOCH (9,6)
7.08
Buy
STOCHRSI (14)
7.08
Buy
MACD (12,26)
-0.05
Buy
ADX (14)
32.12
Neutral
Williams %R
-92.92
Buy
CCI (14)
-89.38
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
21.28
Sell
ROC
-26.32
Sell
Defence Therapeutics’s (DTCFF) Relative Strength Index (RSI) is 21.48, creating a Buy signal.
Defence Therapeutics’s (DTCFF) Trend Strength Indicator (ADX) is 32.12, creating a Neutral signal.
Defence Therapeutics’s (DTCFF) Commodity Channel Index (CCI) is -89.38, creating a Neutral signal.
Defence Therapeutics’s (DTCFF) Price Rate of Change (ROC) is -26.32, creating a Sell signal.

FAQ

Is DTCFF a Buy, Hold, or Sell?
Based on DTCFF’s technical indicators, DTCFF is a Sell.
    What is DTCFF’s RSI (14)?
    DTCFF’s RSI (14) is 21.48, which suggests DTCFF is a Buy.
      What is DTCFF’s MACD?
      DTCFF’s MACD is -0.05, which suggests DTCFF is a Buy.
        What is DTCFF’s 5-day moving average?
        DTCFF’s 5-day moving average is 0.56, which suggests DTCFF is a Buy.
          What is DTCFF’s 20-day moving average?
          DTCFF 20-day moving average is 0.69, which suggests DTCFF is a Sell.
            What is DTCFF’s 50-day moving average?
            DTCFF’s 50-day moving average is 0.73, which suggests DTCFF is a Sell.
              What is DTCFF’s 200-day moving average?
              DTCFF’s 200-day moving average is 0.60, which suggests DTCFF is a Sell.
                What is DTCFF’s Williams % R (14)?
                DTCFF’s Williams % R (14) is -92.92, which suggests DTCFF is a Buy.
                  What is DTCFF’s CCI (14)?
                  DTCFF’s CCI (14) is -89.38, which suggests DTCFF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis